I'm not a lawyer and I've never played one on tv. Though I

New Post Public Reply Private Reply Replies (2) Message Board
Respert24 KenChowder #111885
819
I'm not a lawyer and I've never played one on tv. Though I did read a few Grisham novels so I feel more than qualified to explain what might be going on here.

Firms like Sidley have many qualified, non-partner lawyers working 100+ hour weeks to hammer out the details on any given case. The partners in the firm are the big dogs. The Ohms and the Resperts, if you will. They don't just join the fight without a reason. Especially when it appears even their janitorial staff could handle it. The JLangs, if you will. So it's either a high profile case (their name in lights), precedent setting litigation (their name in history books), massive money at stake (their bank account), or their overworked and underpaid team of lawyers below them is fucking up (hard to believe given what we've seen from the different documents shared here) that would lead to the inclusion of a Hobson-level partner.

Is this a high profile case?

Not right now. A company is not meeting their contractually obligated duties and won't return property. That's nothing that hasn't happened a thousand times before. But perhaps the team handling this case has run it up the ladder that NSF and Amarex have potentially cost their client billions. Maybe they've seen some evidence there may be more here than just a he said, she said fight? Maybe the more they dig in to this case the more they see potential evidence of a much larger conspiracy to delay or destroy Cytodyn's chances at a drug approval? Regardless, Hobson's involvement is an escalation of Sidley's attention to this case and that speaks to something bigger going on.

Is this a precedent setting case?

Not right now. But if there were any meat to our collective concern that there may be a larger entity doing shady shit behind the scenes to try to destroy Cytodyn, or at bare minimum stifle their progress to the point that they give up and sell LL cheap, it could become a very important case. If it were true that some company or group were doing illegal shit to hurt CYDY and they were able to enlist NSF and Amarex in that battle, Sidley would be very eager to win a case like that and would pull out all the stops. Because CYDY is definitely not the first to go through this kind of thing. I'm not saying this is happening, just that when you add up all the negative pressure it sure does feel like it could be. And that's the kind of thing that would bring a partner down a few floors to the fight.

Is there massive money at stake?

Yes. I think it's most likely that along the way the Sidley team has recognized that there is a potential multi-billion dollar award at the end of this. Which could/would warrant the engagement of Sidley's strongest assets.

Is their team screwing up the case, requiring involvement of the partners?

No. Highly, highly doubtful given the facts of the case and the documents we've seen.

In conclusion, if this Hobson news is real there's an almost 100% probability that it's because there's a larger prize at the end of the road than originally anticipated. The original case is about return of data but this looks to be turning into something much bigger. JLang doesn't bring in a hazmat crew to clean up a couple square feet of loose fertilizer out in the garden section of his Home Depot, he grabs a broom and dustpan. And Sidley doesn't bring in a Hobson for a simple case they already look like they're about to win, they leave it to their overworked and underpaid team.

Of course I want to be rich from my investment here, but revenge against those who have purposefully stood in the way of Cytodyn's progress is nearing the same level of desire lately.

Respert24, resident legal eagle-type and defender of the poor*

*those poor unpurchased filets and bottles of red wine I keep seeing at stores. Just out here trying to do my part keeping the beef and wine industry alive during covid. Sure, some might call me a hero and if I'm honest with myself it's a fitting moniker. But really I'm just an regular, everyday, normal guy. A Jon Lajoie, if you will.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading

Top 5 Most Recently Viewed Articles

Perella Weinberg Partners Prepares for Q3 2024 Financial Results

Updated Category News Views 155

Upcoming Financial Results Announcement from Perella Weinberg Perella Weinberg Partners (NASDAQ:PWP) has excitedly prepared to unveil its financial results for the third quarter of 2024, scheduled for a release on a significant Friday morning. This independent advisory firm has established itself as a leading player in the financial sector, and its upcoming reports are...

Continue Reading
Protalix BioTherapeutics Set for an Inspiring Virtual Conference

Updated Category News Views 251

Protalix BioTherapeutics to Showcase Innovations at Virtual Conference Protalix BioTherapeutics, Inc. (NYSE American: PLX), a leader in biopharmaceuticals focused on recombinant therapeutic proteins, is gearing up for participation in an upcoming virtual conference. This event, hosted by iAccess Alpha, promises to deliver valuable insights into the company's latest...

Continue Reading
Wingstop and American Red Cross Unite for Wildfire Relief

Updated Category News Views 298

Wingstop's Commitment to Community Support Wingstop Inc. has taken a commendable step to support communities struggling from the effects of devastating wildfires. By partnering with the American Red Cross, they are making it easier for patrons to play a crucial role in wildfire relief efforts. Through their Round-Up campaign, customers can round their order total up to...

Continue Reading
Harvia Plc Declares Exciting New Dividend for Shareholders

Updated Category News Views 192

Harvia Plc Declares New Dividend Announcement Harvia Plc has made an important announcement regarding dividends that will benefit its devoted shareholders. Recently, the company’s Board of Directors confirmed the details for the upcoming dividend payment, setting a record date and payment date that represents a commitment to returning value to its investors. Details of...

Continue Reading
Propy Launches Innovative Instant Onchain Loan for Real Estate

Updated Category News Views 245

Transforming the Real Estate Landscape with Blockchain A groundbreaking approach to purchasing properties has emerged, blending the benefits of cryptocurrency with real estate transactions. Propy is at the forefront of this transformation, bringing forth a novel financing option that allows buyers to leverage both cryptocurrency and their properties as collateral. This...

Continue Reading